enterococci vre atcc700221 (ATCC)
97
Structured Review
ATCC
enterococci vre atcc700221
Enterococci Vre Atcc700221, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 633 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococci+faecium/Enterococcus+faecium/pm39924125-164-51-58
Average 97 stars, based on 633 article reviews
Enterococci Vre Atcc700221, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 633 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterococci+faecium/Enterococcus+faecium/pm39924125-164-51-58
Average 97 stars, based on 633 article reviews
enterococci vre atcc700221 - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
In Vitro:Article Title: Novel quinoline-piperazine hybrids: the design, synthesis and evaluation of antibacterial and antituberculosis properties. Article Snippet: .. Comprehensive antibacterial profile of the novel compounds The newly synthesised compounds 10a–10p and 11a–11k were screened for their in vitro antibacterial activity against Gram-positive pathogens such as methicillin-susceptible Staphylococcus aureus (MSSA) (ATCC 25923), methicillinresistant Staphylococcus aureus (MRSA) (ATCC 33591), methicillin-resistant Staphylococcus epidermidis (clinical MRSE) (AB 735), vancomycin-resistant Enterococci faecalis (VREF) (ATCC 700802) and Activity Assay:Article Title: Novel quinoline-piperazine hybrids: the design, synthesis and evaluation of antibacterial and antituberculosis properties. Article Snippet: .. Comprehensive antibacterial profile of the novel compounds The newly synthesised compounds 10a–10p and 11a–11k were screened for their in vitro antibacterial activity against Gram-positive pathogens such as methicillin-susceptible Staphylococcus aureus (MSSA) (ATCC 25923), methicillinresistant Staphylococcus aureus (MRSA) (ATCC 33591), methicillin-resistant Staphylococcus epidermidis (clinical MRSE) (AB 735), vancomycin-resistant Enterococci faecalis (VREF) (ATCC 700802) and |